"Diagnostics Firm Redcliffe Labs Raises $42M in Series C Round"
Redcliffe Labs, an omnichannel diagnostics service provider, has secured $42 million in Series C funding, led by Denmark's Investment Fund for Developing Countries (IFU) with a $20 million investment, followed by existing investor LeapFrog Investments with $15 million.
The remaining capital came from existing shareholders HealthQuad and Spark Growth Ventures.This funding will fuel Redcliffe's expansion plans, focusing on deepening its presence in Tier-II and Tier-III cities across India.
The company plans to open more labs and collection centers, expand its home collection network, and pursue strategic partnerships and acquisitions .
Redcliffe's goal is to democratize access to high-quality, affordable, and accurate diagnostics for every Indian, particularly in underserved populations.
The company currently operates over 80 labs, processes tests from 2,000 collection centers, and has a network of 1,000 phlebotomists across 220 cities in India .
SOURCE- Business Standard
#RedcliffeLabs, #SeriesCFunding, #HealthcareFunding, #DiagnosticsIndustry #IndianHealthcare , #StartupFunding , #HealthTech ,#MedicalDiagnostics #IndiaExpansion #HealthcareInnovation #FundingNews #StartupNews #IndianStartupEcosystem #HealthcareStartup
Redcliffe Labs, an omnichannel diagnostics service provider, has secured $42 million in Series C funding, led by Denmark's Investment Fund for Developing Countries (IFU) with a $20 million investment, followed by existing investor LeapFrog Investments with $15 million.
The remaining capital came from existing shareholders HealthQuad and Spark Growth Ventures.This funding will fuel Redcliffe's expansion plans, focusing on deepening its presence in Tier-II and Tier-III cities across India.
The company plans to open more labs and collection centers, expand its home collection network, and pursue strategic partnerships and acquisitions .
Redcliffe's goal is to democratize access to high-quality, affordable, and accurate diagnostics for every Indian, particularly in underserved populations.
The company currently operates over 80 labs, processes tests from 2,000 collection centers, and has a network of 1,000 phlebotomists across 220 cities in India .
SOURCE- Business Standard
#RedcliffeLabs, #SeriesCFunding, #HealthcareFunding, #DiagnosticsIndustry #IndianHealthcare , #StartupFunding , #HealthTech ,#MedicalDiagnostics #IndiaExpansion #HealthcareInnovation #FundingNews #StartupNews #IndianStartupEcosystem #HealthcareStartup
"Diagnostics Firm Redcliffe Labs Raises $42M in Series C Round"
Redcliffe Labs, an omnichannel diagnostics service provider, has secured $42 million in Series C funding, led by Denmark's Investment Fund for Developing Countries (IFU) with a $20 million investment, followed by existing investor LeapFrog Investments with $15 million.
The remaining capital came from existing shareholders HealthQuad and Spark Growth Ventures.This funding will fuel Redcliffe's expansion plans, focusing on deepening its presence in Tier-II and Tier-III cities across India.
The company plans to open more labs and collection centers, expand its home collection network, and pursue strategic partnerships and acquisitions .
Redcliffe's goal is to democratize access to high-quality, affordable, and accurate diagnostics for every Indian, particularly in underserved populations.
The company currently operates over 80 labs, processes tests from 2,000 collection centers, and has a network of 1,000 phlebotomists across 220 cities in India .
SOURCE- Business Standard
#RedcliffeLabs, #SeriesCFunding, #HealthcareFunding, #DiagnosticsIndustry #IndianHealthcare , #StartupFunding , #HealthTech ,#MedicalDiagnostics #IndiaExpansion #HealthcareInnovation #FundingNews #StartupNews #IndianStartupEcosystem #HealthcareStartup
